# US 2026/0258008 A1 · Methods and systems for measuring ascorbic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0258008 A1
- Document ID: US20260258008A1
- Status: Published application
- Kind: A1
- Application number: 19/657,372
- Filed: 2026-04-24
- Published: 2026-09-03
- Earliest claimed: 2018-10-03
- Assignees: Laboratory Corporation of America Holdings
- Applicants: Laboratory Corporation of America Holdings
- Inventors: Russell Phillip Grant; William Slade; Erin Fagan
- Web page: https://patentgrep.com/patent/US20260258008A1

## CPC

- C07D 307/60: Two oxygen atoms, e.g. succinic anhydride
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- B01J 39/16: Organic material
- C07D 307/62: Three oxygen atoms, e.g. ascorbic acid
- G01N 33/82: involving vitamins {or their receptors}
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

Disclosed are methods and systems using liquid chromatography/tandem mass spectrometry (LC-MS/MS and 2D-LC-MS/MS) for the analysis of ascorbic acid in biological samples.

## Claims

### Claim at position 1

1-17. (canceled)

### Claim 18

A method for determining an amount of ascorbic acid in a biological sample by tandem mass spectrometry, comprising:
(a) generating a precursor fragment ion from ascorbic acid having a mass to charge ratio (m/z) of about 115 by in-source fragmentation prior to entry of the precursor fragment ion into a quadrupole of a tandem mass spectrometer;
(b) generating a product ion of the precursor fragment ion by tandem mass spectrometry (MS/MS), wherein the product ion has a mass/charge ratio (m/z) of about 87;
(c) detecting the amount of the product ion generated in (b); and
(d) relating the detected product ion to the amount of the ascorbic acid in the biological sample.

### Claim 19 (depends on 18)

The method of claim 18, wherein the biological sample is subjected to a purification step prior to the initial fragmentation step (a).

### Claim 20 (depends on 19)

The method of claim 19, wherein the purification step comprises chromatography and/or precipitation of proteins.

### Claim 21 (depends on 20)

The method of claim 20, wherein the chromatography comprises high performance liquid chromatography (HPLC).

### Claim 22 (depends on 20)

The method of claim 20, wherein the chromatography comprises analytical liquid chromatography.

### Claim 23 (depends on 21)

The method of claim 21, wherein the biological sample is heated at an MS/MS interface.

### Claim 24 (depends on 18)

The method of claim 18, further comprising subjecting the biological sample to liquid-liquid extraction or diluting the biological sample prior to (a).

### Claim 25 (depends on 18)

The method of claim 18, further comprising generating a second product ion of the precursor fragment ion by tandem mass spectrometry (MS/MS), wherein the second production has a mass/charge ratio (m/z) of about 59, detecting the amount of the second product ion, and relating the detected second product ion to the amount of the ascorbic acid in the biological sample.

### Claim 26 (depends on 18)

The method of claim 18, wherein the precursor fragment ion comprises 3,4-dihydroxyfuran-2(5H)-one.

### Claim 27 (depends on 18)

The method of claim 18, wherein the product ion comprises (Z)-prop-1-ene-1,2,3-triol diradical.

### Claim 28 (depends on 18)

The method of claim 18, wherein the lower limit of quantification (LLOQ) of ascorbic acid is 0.05 mg/dL.

### Claim 29 (depends on 18)

The method of claim 18, further comprising, prior to (a), providing a biological sample believed to contain the ascorbic acid and wherein (a) further comprises applying a voltage to an orifice plate.

### Claim 30 (depends on 18)

The method of claim 18, wherein the tandem MS/MS spectrometer is operated in an atmospheric pressure chemical ionization (APCI) mode.

### Claim 31 (depends on 25)

The method of claim 25, wherein the second product ion comprises (Z)-ethene-1,2-diol radical.
